Omega/Fatty Acid ·Strong evidence ·Reviewed May 2026
The most important essential fatty acid supplement. EPA and DHA omega-3s are critical for brain function, heart health, and systemic inflammation control.
The bottom line
Evidence rating strong. Most-documented uses: heart health, brain function, anti-inflammatory. 22 sources indexed (2009–2026), with 62 interaction records on file.
Core mechanism
EPA competes with arachidonic acid, reducing pro-inflammatory eicosanoids (prostaglandins, thromboxanes, leukotrienes) and producing anti-inflammatory resolvins and protectins. DHA is the primary structural fat in brain cell membranes (60% of brain fat), essential for membrane fluidity, synaptic function, and neuroprotection.21,1
Take with a fatty meal for best absorption; refrigerate to prevent oxidation9,11
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Triglyceride (TG).
Assumes about 1 g/day combined EPA plus DHA. Cheap ethyl ester products can look cheaper per softgel but often deliver less absorbed omega-3 per dollar than quality TG products. Updated 2026-04-02.
How much you'd eat to match a supplemental dose.
The exact omega-3 content varies by species and farmed versus wild source.
Therapeutic intakes are possible from seafood but not from one or two fish-oil capsules with low potency.
Dose: 1,000 mg combined EPA+DHA daily1,2
Timing: With a fat-containing meal
Count EPA+DHA, not just total fish oil weight.
Dose: 1,000-2,000 mg EPA-predominant daily
Timing: With food
EPA-heavy ratios are usually preferred for mood-focused use.
Dose: 2,000-3,000 mg combined EPA+DHA daily21,16
Timing: Split with meals
Higher intakes merit attention to bruising or anticoagulant use.
Dose: 2,000-4,000 mg combined EPA+DHA daily
Timing: Split twice daily with meals
Prescription-strength use belongs under clinician guidance.
What to test, the optimal window inside the conventional range, and how long a response takes.
Effective fish oil use should raise the Omega-3 Index over several weeks.1,3
This is the best routine biomarker for tissue omega-3 incorporation.
Fish oil (EPA and DHA) may lower triglycerides in a dose-dependent way, with the largest reductions at higher omega-3 doses and when baseline triglycerides are elevated.9,11
Requires a 9 to 12 hour fast and abstaining from alcohol for 2 to 3 days. Higher doses (roughly 2 to 4 grams combined EPA and DHA daily) drive the clearest effect, and triglycerides can fluctuate, so keep diet consistent before retesting.
Fish oil tends to modestly lower hs-CRP, with effects that are typically small, dose-dependent, and clearest when baseline inflammation is elevated.1,3
No fasting required. Avoid testing during or soon after acute illness, injury, or infection, since these transiently spike hs-CRP and can mask any supplement effect. Retest at the same time of day for consistency.
Where this appears in the symptom-to-supplement map, ranked by relevance.
EPA and DHA reduce hepatic VLDL synthesis and increase triglyceride clearance, producing dose-dependent reductions in serum triglycerides.
Meaningful triglyceride lowering needs roughly 2 to 4 g per day, so lower general-wellness doses are insufficient for hypertriglyceridemia.
High-dose EPA and DHA shift eicosanoid production toward anti-inflammatory mediators, reducing tender and swollen joints and morning stiffness and sometimes lowering NSAID use.8,9
This is adjunctive only and does not replace DMARDs; continue prescribed therapy and rheumatology care. High doses can affect bleeding, so coordinate with your clinician.
EPA-predominant omega-3 support has some of the best supplement evidence for mood support.16,12
Mood-focused use usually favors EPA over DHA.
EPA and DHA dampen inflammatory eicosanoid signaling and support the skin lipid barrier, which may reduce itch in dry or eczema-prone skin.21
Allow 8 to 12 weeks; persistent or generalized itch warrants a clinician to rule out liver, kidney, thyroid, or allergic causes.
EPA and DHA dampen the inflammatory response to muscle microtrauma, which several trials link to reduced soreness and tenderness after eccentric exercise.2
Dose by combined EPA plus DHA content and take consistently for a few weeks, not just on training day.
EPA and DHA reduce inflammatory eicosanoid production, with small trials showing reduced disease activity and NSAID requirement in ankylosing spondylitis.
Adjunctive only; continue biologic or NSAID therapy and rheumatology follow-up. Higher doses had more effect in the available trial.
EPA and DHA omega-3s lower inflammatory signaling at the lacrimal and salivary glands and have shown improvements in tear film stability and ocular dryness scores in some dry eye trials relevant to the sicca complex.
Dry eye omega-3 trial results are mixed, so this is strictly adjunctive to rheumatology and ophthalmology care; dose by EPA+DHA content, not total oil weight, and allow 8 to 12 weeks.
Omega-3s reduce inflammatory signaling that can amplify joint pain and stiffness.21,1
Typically takes several weeks to notice.
EPA and DHA are converted into anti inflammatory and pro resolving mediators (resolvins) that can lower joint inflammation and stiffness.16,21
Choose a third party tested, low oxidation product; effects build over several weeks.
Omega-3s support tear-film quality and ocular-surface comfort.1,2
Dry-eye benefit usually takes several weeks.
High-DHA omega-3 intake associates with slower cognitive decline in cohort studies.5,7
DHA is the key brain-relevant fatty acid for prevention.
Omega-3 fatty acids may support cochlear blood flow and dampen microvascular and inflammatory stress on auditory hair cells, with observational data linking higher intake to lower age-related hearing loss risk.5,10
Evidence is mostly epidemiological; get a baseline audiogram and see an audiologist promptly for any sudden or one-sided hearing change.
Evidence-based stacks that include it, with the exact dose and timing each one uses.
EPA and DHA are studied for triglyceride, inflammatory, and cardiometabolic markers; aging-outcome claims remain indirect.5,21
Provides EPA and DHA for cardiometabolic and dietary omega-3 support; dose and bleeding-risk context matter.5,8
EPA and DHA resolve exercise-induced inflammation via specialized pro-resolving mediators (SPMs)
EPA and DHA are studied for triglyceride and cardiovascular-risk marker support; medication and bleeding-risk context matter.1,4
EPA and DHA are studied for inflammatory-joint-pain contexts, but symptom response and medication changes need clinician guidance.21
DHA is the dominant fatty acid in retinal photoreceptor outer segments; omega-3s also support tear film integrity in dry eye.19,1
The omega-3 fatty acids EPA and DHA are incorporated into muscle cell membranes and can help modulate the inflammatory response to training, with some evidence for reduced delayed-onset muscle soreness; effect sizes vary across studies.2,3
Long-chain omega-3 fatty acids, especially EPA, support neuronal membrane fluidity and help modulate neuroinflammation, pathways associated with mood regulation. Meta-analyses suggest a modest adjunctive benefit, strongest for EPA-predominant formulas.16,2
The omega-3 fatty acids EPA and DHA are substrates for anti-inflammatory and pain-modulating lipid mediators, and a controlled dietary trial reported reduced headache frequency with higher omega-3 intake, though effects were modest. Separate it from blood-thinning medication unless cleared by a clinician.21,2
Omega-3 fatty acids support a healthy inflammatory balance and accumulate in tissue ahead of pregnancy, and higher omega-3 intake is associated with favorable fertility markers in observational data. Causal fertility benefits are not established, so this is a supportive measure.21,2
APOE genotype may influence lipid response to omega-3 therapy in some studies, but clinical utility for supplement selection is not established.
Recommendation: Track both an Omega-3 Index and a lipid panel after starting therapy rather than assuming a genotype-specific response.
Curcumin is fat-soluble and its absorption increases significantly when taken with dietary fat like fish oil. Both share anti-inflammatory pathways.
Recommendation: Take curcumin with fish oil or a fat-containing meal for maximum absorption and synergistic anti-inflammatory effects.
CoQ10 is fat-soluble and absorption increases 3-fold when taken with dietary fat. Fish oil provides the ideal fat vehicle.
Recommendation: Take CoQ10 with fish oil or a fat-containing meal for dramatically improved absorption.
Vitamin D3 is fat-soluble and absorption improves when taken with omega-3 fatty acids. Both support cardiovascular and immune health.
Recommendation: Take D3 with fish oil or a meal containing fat for optimal absorption.
Phosphatidylserine is a phospholipid that benefits from omega-3 DHA, which is preferentially incorporated into PS in brain membranes.
Recommendation: Take together. DHA-enriched phosphatidylserine may be more effective for cognitive function than soy-derived PS.
Astaxanthin is fat-soluble and absorbs best with dietary fat. It also protects omega-3 fatty acids from oxidation.
Recommendation: Take together. Astaxanthin protects fish oil PUFAs from peroxidation while fish oil improves astaxanthin absorption.
Vitamin E protects omega-3 fatty acids from lipid peroxidation. High-dose fish oil may increase vitamin E requirements.
Recommendation: Take vitamin E with fish oil to prevent PUFA oxidation. Many quality fish oil supplements include vitamin E for this reason.
K2 (MK-7) is fat-soluble and absorption increases with dietary fat. Fish oil provides an excellent fat vehicle.
Recommendation: Take K2 with fish oil or a fat-containing meal for optimal absorption.
Both have blood-thinning properties. High doses of both together may increase bleeding risk.
Recommendation: At standard doses, this combination is generally safe and synergistic. Monitor for easy bruising at high doses. Discontinue before surgery.
Resveratrol is lipophilic and absorbs better with dietary fat. Both have anti-inflammatory and cardioprotective properties.
Recommendation: Take resveratrol with fish oil or a fat-containing meal for improved bioavailability.
High-dose fish oil increases vitamin E requirements because PUFAs are susceptible to peroxidation. May deplete vitamin E stores.
Recommendation: If taking high-dose fish oil (>3g/day), ensure adequate vitamin E intake to prevent PUFA-induced vitamin E depletion.
K2 (MK-7) is fat-soluble and absorption increases with dietary fat. Fish oil provides an excellent fat vehicle.
Recommendation: Take K2 with fish oil or a fat-containing meal for optimal absorption.
Curcumin is fat-soluble and its absorption increases significantly when taken with dietary fat like fish oil. Both share anti-inflammatory pathways.
Recommendation: Take curcumin with fish oil or a fat-containing meal for maximum absorption and synergistic anti-inflammatory effects.
Numbered references. Citations throughout the page link here.
Shokravi A, Sharma S, Singh R et al.. Omega-3 polyunsaturated fatty acid exposure and cardiovascular outcomes in dialysis: a systematic review and meta-analysis. Future cardiology. 2026
Omega-3 supplementation combined with resistance training improved muscle strength and functional performance compared to training alone.
Javaid M, Kadhim K, Bawamia B et al.. Bleeding Risk in Patients Receiving Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Journal of the American Heart Association. 2024
Yan J, Liu M, Yang D et al.. Efficacy and Safety of Omega-3 Fatty Acids in the Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis. Cardiovascular drugs and therapy. 2024
Higher omega-3 intake and blood levels were associated with reduced risk of dementia and cognitive decline in prospective cohort studies.
Chang JP, Tseng PT, Zeng BS et al.. Safety of Supplementation of Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Advances in nutrition (Bethesda, Md.). 2023
Wang WX, Ko ML. Efficacy of Omega-3 Intake in Managing Dry Eye Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of clinical medicine. 2023
Optimal combined intake of omega-3 fatty acids for blood pressure lowering is likely between 2 g/d and 3 g/d.
Omega-3 supplements associated with 25% increased AF risk; >1 g/day increased risk by 49% vs 12% for <=1 g/day, indicating dose-dependent relationship.
Marine omega-3 supplementation was associated with reduced risk of myocardial infarction, CHD death, total CHD, and CVD death in a dose-dependent manner.
Omega-3 PUFA supplementation significantly reduced depressive symptoms, with higher doses of EPA showing greater efficacy.
EPA-predominant formulations (>60% EPA) demonstrated clinical benefit in depression, whereas DHA-predominant formulations did not.
DHA, the dominant omega-3 in the brain, impacts neurotransmitters and brain functions and has evidence for slowing cognitive decline.
EPA and DHA inhibit leucocyte chemotaxis, reduce pro-inflammatory cytokines, and give rise to anti-inflammatory resolvins, protectins, and maresins.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
NutriStack